(Total Views: 696)
Posted On: 05/18/2021 5:46:09 PM
Post# of 154647
I guess that $25 million wasn’t for more product. Nader said on the call today that they have not ordered or requested any additional drug from Samsung. On April 5th though he said:
Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, stated, “...This infusion of capital will help ensure we have sufficient quantities of leronlimab available upon any potential approvals for COVID-19 treatment.”
...and everyone here fell for it. Again.
Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, stated, “...This infusion of capital will help ensure we have sufficient quantities of leronlimab available upon any potential approvals for COVID-19 treatment.”
...and everyone here fell for it. Again.
(3)
(4)
